Bristol-Myers Squibb (Switzerland)
In research, Bristol-Myers Squibb (Switzerland) stands highest in Life Sciences (#5,708 of 14,347 worldwide), Medicine (#7,764 of 17,978 worldwide) and Health Sciences (#10,275 of 20,462 worldwide), over all time.
- World rank, 2022–2025
- #21,196 of 28,054 · #11,893 all time
- Rank in Switzerland
- #158 of 220
- Research works
- 636 ▼ 6% vs 2013–17
- Citations
- 22k 34.6 per fractional work
- Top-10% rate
- 10.3% record average 16.5%
- Open access
- 46% world 28%
What is Bristol-Myers Squibb (Switzerland) known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| Life SciencesDomain | #5,708 of 14,347 | 24.8% | 188 | |
| MedicineField | #7,764 of 17,978 | 21.4% | 239 | |
| Health SciencesDomain | #10,275 of 20,462 | 21.2% | 253 | |
| Biochemistry, Genetics and Molecular BiologyField | #5,167 of 7,814 | 26.8% | 128 |
Each strip is that field’s whole ranked pool, with the notch where Bristol-Myers Squibb (Switzerland) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Economics, Econometrics and Finance, 2.9×. Every wedge is a field page.
- Economics, Econometrics and Finance 2.9×
- Mathematics 2.8×
- Arts and Humanities 2.3×
- Pharmacology, Toxicology and Pharmaceutics 1.6×
- Medicine 1.5×
- Biochemistry, Genetics and Molecular Biology 1.5×
- Social Sciences 1.5×
- Immunology and Microbiology 1.4×
- Agricultural and Biological Sciences 1.0×
- Earth and Planetary Sciences 0.8×
- Health Professions 0.8×
- Nursing 0.8×
- Psychology 0.7×
- Energy 0.6×
- Environmental Science 0.5×
- Business, Management and Accounting 0.5×
- Engineering 0.5×
- Decision Sciences 0.4×
- Neuroscience 0.4×
- Chemical Engineering 0.4×
- Physics and Astronomy 0.3×
- Computer Science 0.3×
- Dentistry 0.2×
- Chemistry 0.1×
- Materials Science 0.1×
Who are the top researchers at Bristol-Myers Squibb (Switzerland)?
Ranked on the composite score, Laura G. Corral, Daniel Weiß and Antonia Lopez‐Girona lead among researchers whose main affiliation is Bristol-Myers Squibb (Switzerland).
- 1 Laura G. Corral Switzerland · #229,521 worldwide 149 citations · 19 works
- 2 Daniel Weiß Switzerland · #423,499 worldwide 30 citations · 22 works
- 3 Antonia Lopez‐Girona Switzerland · #443,009 worldwide 57 citations · 16 works
- 4 George W. Muller Switzerland · #502,633 worldwide 137 citations · 15 works
- 5 Peter Schäfer Switzerland · #748,783 worldwide 82 citations · 46 works
Which keywords describe research at Bristol-Myers Squibb (Switzerland)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Economic Growth, Public Economics, Regional Development, Minimal Residual Disease, Lymphoma, Proteasome Inhibitors, Diagnosis Criteria and International Myeloma Working Group.
- PET Imaging
- JAK2 Mutation
- Targeted Therapy
- Chimeric Antigen Receptor
- Prognostic Scoring System
- Equivalent Circuit Concept
- Assessment
- AML
- Rituximab
- Wireless Communication
- Hematopoietic Stem Cells
- Tumor Microenvironment
- Economic Development
- Colonialism
- Proteasome Inhibitors
- Lymphoma
- Diagnosis Criteria
- Regional Development
- Economic Growth
- Epidemiology
- Globalization
- Sustainability
- Public Economics
- Minimal Residual Disease
- International Myeloma Working Group
- Prognostic Factors
- Immunotherapy
- Innovation
- Human Rights
- Cancer Immunotherapy
- Leukemia
- Bayesian Methods
- Tourism
- Acute Myeloid Leukemia
- Electric Circuits
- Genetic Regulation
- CAR T Cells
- Sickle-cell Disease
- Thalassemia
- Myelofibrosis
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Globalization6▲ 2.4×15 topics
- Epidemiology6◆ 1.12×27 topics
- Sustainability6▲ 1.80×17 topics
- Economic Growth6▲ 5.0×4 topics
- Public Economics4▲ 36×1 topic
- Regional Development4▲ 9.2×1 topic
- Minimal Residual Disease4▲ 46×2 topics
- Diagnosis Criteria4▲ 83×1 topic
- International Myeloma Working Group4▲ 83×1 topic
- Lymphoma4▲ 19×3 topics
- Prognostic Factors4▲ 6.8×10 topics
- Proteasome Inhibitors4▲ 42×2 topics
- Immunotherapy4▲ 4.0×10 topics
- Colonialism4▲ 6.0×7 topics
- Innovation4▲ 2.6×6 topics
- Economic Development3▲ 3.1×6 topics
- Human Rights3▲ 2.5×11 topics
- Tumor Microenvironment3▲ 4.9×6 topics
- Cancer Immunotherapy3▲ 14×3 topics
- Hematopoietic Stem Cells3▲ 23×3 topics
- Leukemia2▲ 22×2 topics
- Wireless Communication2▲ 13×2 topics
- Bayesian Methods2▲ 37×2 topics
- Rituximab2▲ 12×3 topics
- Tourism2▲ 19×3 topics
- AML2▲ 35×1 topic
- Acute Myeloid Leukemia2▲ 35×1 topic
- Assessment2▲ 15×2 topics
- Electric Circuits2▲ 55×1 topic
- Equivalent Circuit Concept2▲ 55×1 topic
- Genetic Regulation2▲ 11×2 topics
- Prognostic Scoring System2▲ 45×2 topics
- CAR T Cells2▲ 23×1 topic
- Chimeric Antigen Receptor2▲ 23×1 topic
- Sickle-cell Disease2▲ 39×1 topic
- Targeted Therapy2▲ 7.7×5 topics
- Thalassemia2▲ 39×1 topic
- JAK2 Mutation2▲ 69×1 topic
- Myelofibrosis2▲ 69×1 topic
- PET Imaging2▲ 8.9×4 topics
Which research topics does Bristol-Myers Squibb (Switzerland) publish most on?
By volume in 2022–2025: Economic Growth and Fiscal Policies, Multiple Myeloma Research and Treatments, Acute Myeloid Leukemia Research and Engineering and Technology Innovations.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Economic Growth and Fiscal Policies Economics and Econometrics 4 works
- 2 Multiple Myeloma Research and Treatments Hematology 4 works
- 3 Acute Myeloid Leukemia Research Hematology 2 works
- 4 Engineering and Technology Innovations Electrical and Electronic Engineering 2 works
- 5 Hemoglobinopathies and Related Disorders Genetics 2 works
- 6 CAR-T cell therapy research Oncology 2 works
- 7 Myeloproliferative Neoplasms: Diagnosis and Treatment Genetics 2 works
- 8 Cancer Immunotherapy and Biomarkers Oncology 2 works
- 9 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 2 works
- 10 Statistical Methods in Clinical Trials Statistics and Probability 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Bristol-Myers Squibb (Switzerland)'s research output changed?
Output in 2018–2022 was 6% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.